Search results for: 'Preferred Destination for Clinical Trials 2020'
- Did you mean
- preferred desalination for clinical trials 2020
- preferred destination for clinical trials 2014
- Related search terms
- 2020 us editing plan service market
- 2020 us editing part service market
- forces managed security services market study
- 2020 us editing pacif service market
- 2020 us editing post service market
-
28 Feb 2022  |  North America  |  Market Research
United States Clinical Laboratory Services Growth Opportunities
Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites
The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to val...
$2,450.00
Special Price $1,837.50 save 25 %
-
16 Dec 2005  |  North America  |  Market Research
U.S. Clinical Laboratory Analyzer Markets
This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...
$2,450.00
Special Price $1,837.50 save 25 %
-
11 Dec 2020  |  North America  |  Market Research
Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020
Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity
The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...
$2,450.00
Special Price $1,837.50 save 25 %
-
23 Dec 2020  |  North America  |  Market Research
Growth Opportunity Analysis of the North American Clinical Documentation Improvement (CDI) Market
Internal Challenges, Disruptive Technologies, and Competitive Intensity are Driving CDI to become a More Value-based Process
This Frost & Sullivan research service presents a comprehensive overview of the North American clinical documentation improvement (CDI) market. CDI is a mid-process in the broader revenue cycle management (RCM) ecosystem. This study analyzes key product segments, major end users, and top vendors across the United States and Canada. Revenue is fo...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Feb 2004  |  North America  |  Market Research
U.S. Clinical Chemistry and Immunoassay Reagents Markets
Clinical diagnostic tests have long been used as a means of screening, diagnosing, and monitoring disease. Two common methods used in obtaining reportable results for clinical laboratory tests are clinical chemistry and immunoassay techniques. Clinical chemistry tests are analytical human biochemistry tests. Immunoassays, on the other hand, are ...
$2,450.00
Special Price $1,837.50 save 25 %
-
22 Oct 2015  |  North America  |  Market Research
Analysis of the US Clinical Laboratories Market
Decentralization will Significantly Increase Retail Setting Test Volume by 2017
This research service evaluates the US clinical laboratories market. The analysis provides extensive understanding of test distribution in independent laboratories (reference and specialized), physician office laboratories, hospital-based labs, and others including retail clinics and mobile diagnostic centers. The study covers the potential impact ...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Mar 2019  |  North America  |  Technology Research
Breakthroughs in Non-Alcoholic Steatohepatitis Management
Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development
Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...
$4,950.00
Special Price $3,712.50 save 25 %
-
03 Feb 2021  |  North America  |  Market Research
Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market
Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities
2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Jun 2019  |  North America  |  Market Research
US Clinical Decision Support Systems Market, Forecast to 2024
A Growing Market with an Opportunity to be More than an Adjunct to the EHR
Clinical Decision Support (CDS) systems are poised to become the user interface of choice for clinical interaction with health IT, ultimately supplanting the EHR system as the primary health IT point of interface for clinicians. This is due the fact that CDS began as a way to deliver medical content and patient information to the caregiver. Unlike ...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Sep 2019  |  North America  |  Frost Radar
Frost Radar in the Immunoassay and Clinical Chemistry Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...
$4,950.00
Special Price $3,712.50 save 25 %